Tag: Steatohepatitis

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Steatohepatitis

Akero Therapeutics Announces Proposed Public Offering of Common Stock

Added to Collection on: 2025-01-27 21:11:34

Tags for this article:

Initial public offering
Financial markets
U.S. Securities and Exchange Commission
Prospectus
Corporate finance
Forward-looking statement
Shelf registration
Public offering
Registration statement
Steatohepatitis
Cirrhosis
Underwriting
Akero Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to ...

Added to Collection on: 2025-05-14 15:38:27

Tags for this article:

Hepatitis
Health effects of alcohol
Hepatology
Metabolic dysfunction–associated steatotic liver disease
Non-alcoholic fatty liver disease
Fatty liver disease
Steatohepatitis
Liver disease
Cirrhosis
GSK plc
Alcoholic liver disease
Liver cancer

Click the tags to see associated articles and topics

View Article Details
HistoIndex launches AI-based LDT for MASH fibrosis assessment - Medical Device Network

Added to Collection on: 2025-08-12 16:46:28

Tags for this article:

Hepatitis
Health effects of alcohol
Metabolic dysfunction–associated steatotic liver disease
Non-alcoholic fatty liver disease
Steatohepatitis
Fatty liver disease
Laboratory-developed test
Liver disease
GlobalData
Mash
Fibrosis

Click the tags to see associated articles and topics

View Article Details
Novo's Wegovy becomes first GLP-1 drug approved for MASH | BioPharma Dive

Added to Collection on: 2025-08-18 13:04:37

Tags for this article:

Peptide hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Anti-diabetic drugs
Lipopeptides
Semaglutide
Anti-obesity medication
Metabolic dysfunction–associated steatotic liver disease
Novo Nordisk
Glucagon-like peptide-1
Steatohepatitis
Fatty liver disease

Click the tags to see associated articles and topics

View Article Details
Roche to buy Nasdaq-listed 89bio for up $3.5bn - Sharecast.com

Added to Collection on: 2025-09-18 16:32:59

Tags for this article:

Hepatitis
Metabolic disorders
Metabolic syndrome
Metabolic dysfunction–associated steatotic liver disease
Steatohepatitis
Roche
Obesity
Comorbidity

Click the tags to see associated articles and topics

View Article Details
New Study Reveals 3 Major Risk Factors for Deadly Liver Disease Affecting 1 in 5 People in the UK

Added to Collection on: 2025-09-20 20:50:04

Tags for this article:

Hepatitis
Endocrine diseases
Metabolic disorders
Metabolic dysfunction–associated steatotic liver disease
Non-alcoholic fatty liver disease
Fatty liver disease
Metabolic syndrome
Diabetes
Liver disease
Steatohepatitis
Ruminococcus torques
United Kingdom

Click the tags to see associated articles and topics

View Article Details
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal

Added to Collection on: 2025-09-30 16:42:13

Tags for this article:

Hepatitis
Stock market
Economy of New York City
NASDAQ
Steatohepatitis
Roche
Metabolic dysfunction–associated steatotic liver disease
Meta Platforms
Mash
Stock
Short
89BIO, INC.

Click the tags to see associated articles and topics

View Article Details
Surprising study reveals what really kills fatty liver disease patients | ScienceDaily

Added to Collection on: 2025-10-04 16:27:44

Tags for this article:

Hepatitis
Metabolic dysfunction–associated steatotic liver disease
Non-alcoholic fatty liver disease
Diabetes
Endocrine diseases
Metabolic disorders
Prediabetes
Type 2 diabetes
Obesity
Steatohepatitis

Click the tags to see associated articles and topics

View Article Details
Novo joins MASH dealmaking surge with $4.7B Akero buyout | BioPharma Dive

Added to Collection on: 2025-10-09 16:31:22

Tags for this article:

Hepatitis
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
Efruxifermin
Semaglutide
Novo Nordisk
Metabolic dysfunction–associated steatotic liver disease
Fibroblast growth factor 21
Fatty liver disease
Steatohepatitis
Liver disease

Click the tags to see associated articles and topics

View Article Details
Novo buys again: 5-billion-dollar deal for Akero´s MASH

Added to Collection on: 2025-10-09 17:30:50

Tags for this article:

Hepatitis
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Lipopeptides
Semaglutide
Novo Nordisk
Metabolic dysfunction–associated steatotic liver disease
Maziar Mike Doustdar
Steatohepatitis
Mash
Efruxifermin
GSK plc
Akero Therapeutics

Click the tags to see associated articles and topics

View Article Details
Book a Demo